Back to funds

Novo Holdings A/S

Updated 6 days ago

Managed by Novo Holdings A/S • Latest filing Q3 2026

Portfolio value
$1.5B
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$1.3B
Q1 2026$1.2B
Q2 2026$1.7B
Q3 2026$1.5B

Top holdings

27 positions as of Q3 2026

View filing
E

EDGEWISE THERAPEUTICS INC

Value
$217.2M
Shares
5.35M
% Port
14.58%
A

ASML HOLDING N V

Value
$172M
Shares
94.9K
% Port
11.55%
B

BROOKFIELD CORP

Value
$162.8M
Shares
4.47M
% Port
10.93%
C

HEMAB THERAPEUTICS HLDGS INC

Value
$128.9M
Shares
4.18M
% Port
8.65%
A

AVALYN PHARMACEUTICALS INC

Value
$98.3M
Shares
3.45M
% Port
6.60%
M

MIRUM PHARMACEUTICALS INC

Value
$96.2M
Shares
1.13M
% Port
6.46%
C

SALESFORCE INC

Value
$90.3M
Shares
393.2K
% Port
6.06%
E

ENLIVEN THERAPEUTICS INC

Value
$45.8M
Shares
1.00M
% Port
3.08%
F

4D MOLECULAR THERAPEUTICS IN

Value
$42.9M
Shares
3.00M
% Port
2.88%
O

OBSIDIAN THERAPEUTICS INC

Value
$42.9M
Shares
3.12M
% Port
2.88%
P

VAXCYTE INC

Value
$40.4M
Shares
710.0K
% Port
2.71%
F

FLOOR & DECOR HLDGS INC

Value
$36.5M
Shares
797.0K
% Port
2.45%
V

VIRIDIAN THERAPEUTICS INC

Value
$36M
Shares
1.75M
% Port
2.42%
A

ARRIVENT BIOPHARMA INC

Value
$35.6M
Shares
1.18M
% Port
2.39%
I

INSMED INC

Value
$32.5M
Shares
284.4K
% Port
2.18%
P

PHARVARIS N V

Value
$32.3M
Shares
1.02M
% Port
2.17%
C

CELLDEX THERAPEUTICS INC NEW

Value
$30.8M
Shares
950.0K
% Port
2.07%
B

ALIBABA GROUP HLDG LTD

Value
$27.7M
Shares
257.3K
% Port
1.86%
X

XENON PHARMACEUTICALS INC

Value
$24.3M
Shares
652.1K
% Port
1.63%
S

SCHOLAR ROCK HLDG CORP

Value
$22.2M
Shares
460.0K
% Port
1.49%

Explore